Evidence map›Paper›PMID 40231943›Full record

ArticleFoods (Basel, Switzerland)2025

Importance-Performance Map Analysis of the Drivers for the Acceptance of Genetically Modified Food with a Theory of Planned Behavior Groundwork.

Jorge de Andrés-Sánchez, María Puelles-Gallo, Mar Souto-Romero, Mario Arias-Oliva

Abstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jorge de Andrés-SánchezSocial and Business Research Lab, Universitat Rovira i Virgili, Campus de Bellissens, 43204 Reus, Spain.ORCID 0000-0002-7715-779X
María Puelles-GalloDepartment of Marketing, Complutense University of Madrid, Campus de Somosaguas, s/n, Edif. 6, 28224 Pozuelo de Alarcón, Spain.
Mar Souto-RomeroDepartment of Business Economics, Rey Juan Carlos University, Paseo de los Artilleros, 38, Vicálvaro, 28032 Madrid, Spain.ORCID 0000-0001-9364-3539
Mario Arias-OlivaDepartment of Marketing, Complutense University of Madrid, Campus de Somosaguas, s/n, Edif. 6, 28224 Pozuelo de Alarcón, Spain.ORCID 0000-0002-6874-4036

Funding

Telefonica Chair on Smart Cities of the Universitat Rovira i Virgili and Universitat de Barcelona 42.DB.00.18.00
6 · The paper itself

Abstract

The revolution in biotechnology at the end of the 20th century has improved agricultural productivity, reduced environmental impact, and enhanced food nutrition. However, genetically modified food (GMF) consumption remains low, particularly in the European Union, including Spain. This study develops a GMF acceptance model based on the Theory of Planned Behavior, incorporating five key variables alongside gender and age as control factors. Attitude-related variables include perceived benefit (PB) and perceived risk (PR). Perceived control factors involve food neophobia (PHOB) and knowledge (KNOWL) about GMFs. Additionally, subjective norm (SN) is considered. Using a sample of 728 Spanish consumers, the model was validated, explaining 70% of the variance and demonstrating strong predictive capability. The results so PB, KNOWL, and SN positively influence GMF acceptance, whereas PR and PHOB have negative effects. PB and SN emerged as the most influential variables, which are also highlighted as priorities in the importance-performance map analysis (IPMA). Based on these findings, strategies have been proposed to enhance perceived benefits and influence subjective norms, potentially increasing GMF acceptance. This study provides valuable insights into consumer behavior and offers guidance for policymakers and industry stakeholders to promote the adoption of GMFs.

Indexed as

genetic edited foodgenetic modified foodimportance–performance map analysistheory of planned behavior

Identifiers

PMID40231943
PMCPMC11941352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.